SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

    During July 2024, the Company entered into a definitive agreement to acquire all of the outstanding shares of LifeLabs Inc. and all of the partnership interests of BPC Lab Finance LP (collectively "LifeLabs") for a cash purchase price based on a value of approximately C$1.35 billion Canadian Dollars (approximately $985 million U.S. Dollars), including net debt, subject to customary purchase price adjustments. LifeLabs provides laboratory diagnostic information and digital health connectivity systems in Canada. The closing of the acquisition is subject to certain closing conditions, including obtaining consents from certain key customers of LifeLabs, obtaining clearance under the Competition Act (Canada), and there not being any notice or order in effect under the Investment Canada Act which prohibits closing. The transaction is expected to close by the end of 2024, subject to satisfaction of certain closing conditions and approvals, including receipt of the consents and closing conditions described above. The Company expects to fund the acquisition through cash on hand and debt.